KUALA LUMPUR, March 19 (Bernama) -- AstraZeneca has made its rare disease treatment Soliris available in Malaysia, marking a significant advancement in treatment options for patients with rare ...

AstraZeneca, a global, science-led biopharmaceutical company, has made available its treatment, Soliris®, in Malaysia as part of its ongoing ...

For decades, the global energy system has been closely tied to one narrow maritime passage: the Strait of Hormuz. Nearly ...

Sudden loss triggers distinct neurological consequences, with auditory memory playing a central role in how the brain ...

Explore how North African power could be Europe's next energy lever with new electricity interconnections and gas infrastructure.

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

After teasing a new regulatory process for personalized genetic medicines at the end of last year, the FDA today unveiled draft guidance for an approval pathway that could see custom CRISPR therapies, ...

Compass Pathways has announced that its investigational psilocybin treatment has successfully met its primary endpoint in a second Phase 3 clinical trial moving it one step closer to FDA submission.

Suleman said he recently toured the construction site and expressed satisfaction with the quality of the work and the design of the facilities, noting that the infrastructure meets the standards ...

Capturing $22B+ Untapped Market with a Proprietary Technology Stack Built for Global Scale and Unrestricted AI Sandbox WILMINGTON, DE, UNITED STATES, March 10, 2026 /EINPresswire.com/ — NEXTPlay is ...